Seaport Global Sticks to Their Hold Rating for Visa (V)
A Quick Look at Today's Ratings for Visa(V.US), With a Forecast Between $279 to $325
Visa's Growth Prospects Remain Strong Despite Core Payment Deceleration; Analyst Reiterates Buy Rating
Maintaining Hold: Visa's Q3 Underperformance and Decelerating Growth Prompt Cautious Outlook
Deutsche Bank Adjusts Price Target on Goldman Sachs Group to $500 From $400, Maintains Hold Rating
Buy Rating Affirmed for Visa: Strong Q3 Growth and Positive Outlook Despite Headwinds
Visa (V) Gets a Buy From UBS
Piper Sandler Adjusts Price Target on Visa to $319 From $322, Maintains Overweight Rating
China Renaissance Adjusts Price Target on Microsoft to $520 From $470, Maintains Buy Rating
Visa Analyst Ratings
Maintaining Hold on Visa: Assessing Slowing Growth and Competitive Pressures
Analysts Offer Insights on Financial Companies: Chubb (CB), MSCI (MSCI) and Visa (V)
Goldman Sachs Remains a Buy on Visa (V)
KBW Reaffirms Their Buy Rating on Visa (V)
Visa Maintains Buy Rating Amid Consistent Performance and Growth Prospects
Cantor Fitzgerald Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $591
UnitedHealth Group Analyst Ratings
Redburn Atlantic Adjusts Price Target on Goldman Sachs to $450 From $400
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $360
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344